Literature DB >> 2997160

Chemotactic factor-induced activation of Na+/H+ exchange in human neutrophils. II. Intracellular pH changes.

L Simchowitz.   

Abstract

The intracellular pH (pHi) changes resulting from chemotactic factor-induced activation of Na+/H+ exchange in isolated human neutrophils were characterized. Intracellular pH was measured from the equilibrium distribution of [14C]-5,5-dimethyloxazolidine-2,4-dione and from the fluorescence of 6-carboxyfluorescein. Exposure of cells to 0.1 microM N-formyl-methionyl-leucyl-phenylalanine (FMLP) in 140 mM Na+ medium at extracellular pH (pHo) 7.40 led to a rise in pHi along an exponential time course (rate coefficient approximately 0.55 min-1). By 10 min, a new steady-state pHi was reached (7.75-7.80) that was 0.55-0.60 units higher than the resting pHi of control cells (7.20-7.25). The initial rate of H+ efflux from the cells (approximately 15 meq/liter X min), calculated from the intrinsic intracellular buffering power of approximately 50 mM/pH, was comparable to the rate of net Na+ influx (approximately 17 meq/liter X min), an observation consistent with a 1:1 stoichiometry for Na+/H+ exchange. This counter-transport could be inhibited by amiloride (apparent Ki approximately 75 microM). When either the external ([Na+]o) or internal Na ([Na+]i) concentrations, pHo, or pHi were varied independently, the new steady-state [Na+]i and pHi values in FMLP-stimulated cells were those corresponding to a chemical equilibrium distribution of Na+ and H+ across the cell membrane. By analogy to other activated cells, these results indicate that an alkalinization of pHi in human neutrophils is mediated by a chemotactic factor-induced exchange of internal H+ for external Na+.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997160

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Mechanisms of calcium homeostasis in the polymorphonuclear leucocyte.

Authors:  J Westwick; C Poll
Journal:  Agents Actions       Date:  1986-10

2.  Proton currents in human granulocytes: regulation by membrane potential and intracellular pH.

Authors:  N Demaurex; S Grinstein; M Jaconi; W Schlegel; D P Lew; K H Krause
Journal:  J Physiol       Date:  1993-07       Impact factor: 5.182

3.  Protein kinase C activates an H+ (equivalent) conductance in the plasma membrane of human neutrophils.

Authors:  A Nanda; S Grinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 4.  How neutrophils kill microbes.

Authors:  Anthony W Segal
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  Ligation of the alpha 2-macroglobulin signalling receptor on macrophages induces protein phosphorylation and an increase in cytosolic pH.

Authors:  U K Misra; G Gawdi; S V Pizzo
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

6.  Activation of H+ conductance in neutrophils requires assembly of components of the respiratory burst oxidase but not its redox function.

Authors:  A Nanda; J T Curnutte; S Grinstein
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Phorbol 12-myristate 13-acetate activates an electrogenic H(+)-conducting pathway in the membrane of neutrophils.

Authors:  A Kapus; K Szászi; E Ligeti
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

8.  Leukocyte chemoattraction by 1,2-diacylglycerol.

Authors:  T M Wright; R D Hoffman; J Nishijima; L Jakoi; R Snyderman; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Activation of multiple pH-regulatory pathways in granulocytes by a phosphotyrosine phosphatase antagonist.

Authors:  L Bianchini; A Nanda; S Wasan; S Grinstein
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

Review 10.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.

Authors:  Andrew R Cross; Anthony W Segal
Journal:  Biochim Biophys Acta       Date:  2004-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.